New PET scan could slash radiation by 100x
NCT ID NCT07542158
First seen Apr 29, 2026 · Last updated Jun 23, 2026 · Updated 10 times
Summary
This study tests a new PET imaging technique that uses 10 to 100 times less radiation than standard scans. Researchers will inject 200 healthy volunteers and patients with a radioactive tracer and use a high-sensitivity scanner to see if image quality remains good enough for detecting Parkinsonian syndromes, neuroendocrine tumors, and gliomas. The goal is to make scans safer without losing diagnostic accuracy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE (NE) TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nuclear Imaging Institute
Englewood, New Jersey, 07631, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
18F-FDOPA (a radioactive tracer)
What this could lead to
If successful, this could make PET scans safer by drastically reducing radiation exposure while maintaining image quality.
What could go wrong
This is an early-phase imaging study focused on technical improvements, not a treatment. It may not lead to changes in patient care or diagnosis.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.